Actively Recruiting

Age: 40Years - 90Years
All Genders
NCT06429969

Metabolomic Profile of Vitreoretinal Diseases: an NMR-Based Approach Using Vitreous.

Led by Renmin Hospital of Wuhan University · Updated on 2024-05-28

450

Participants Needed

1

Research Sites

206 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this observational study was to learn about metabolomics profiles in vitreoretinal diseases by nuclear magnetic resonance (NMR)using vitreous fluid. The main question it aimed to answer was abnormal biomarkers for common retinal diseases such as idiopathic macular hole(IMH), diabetic retinopathy(DR) and retinal detachment(RD). Participants would not be subjected to any intervention and the investigators would only collect preoperative information and remaining vitreous samples. The investigators divided the participants into groups with appropriate disease names based on the disease diagnosis, such as IMH group, DR group, and RD group. The MH group was used as a control group, investigators compared other groups to see the metabolomic abnormalities.

CONDITIONS

Official Title

Metabolomic Profile of Vitreoretinal Diseases: an NMR-Based Approach Using Vitreous.

Who Can Participate

Age: 40Years - 90Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of idiopathic macular hole (IMH) requiring pars plana vitrectomy (PPV) surgery
  • Diagnosis of diabetic retinopathy (DR) requiring PPV surgery
  • Diagnosis of retinal detachment (RD) requiring PPV surgery
  • Diagnosis of idiopathic macular epiretinal membrane (IMM) requiring PPV surgery
  • Diagnosis of retinal vein occlusion (RVO) requiring PPV surgery
Not Eligible

You will not qualify if you...

  • Vitreoretinal disease not requiring PPV surgery
  • Previous history of PPV surgery
  • Presence of other active eye diseases such as acute conjunctivitis or uveitis
  • Presence of serious systemic diseases like hypertension or diabetes mellitus

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Eye, Center, Renmin Hospital of Wuhan University

Wuhan, Hubei, China, 430060

Actively Recruiting

Loading map...

Research Team

L

Liwei Cheng

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

5

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here